Written by: Katrine Svensmark
Explore the world of fibroids, their appearance, location, growth patterns, and impact on menstruation, and debunk common myths surrounding their nature, including their potential for cancer, infertility, and shrinkage.
What are Fibroids?
Fibroids, also known as uterine leiomyomas, are noncancerous tumors that develop in the uterus. These tumors originate from the smooth muscle cells of the uterus and can vary greatly in size and location. Despite being a common condition, there are often misconceptions about fibroids, their appearance, and the effects they can have on a person’s health.
In this article, we will delve into the various aspects of fibroids, including their appearance, location, types, growth patterns, and their impact on menstruation. Additionally, we will address common myths associated with fibroids to provide a better understanding of this condition. By shedding light on these topics, we aim to increase awareness and promote accurate knowledge about fibroids.
Understanding the Appearance of Fibroids: Size, Texture, and Variations
Fibroids can vary in size, ranging from small, undetectable growths to large masses that can distort the shape of the uterus. They typically have a firm, rubbery texture and can appear as singular or multiple growths.
Fibroids are commonly described as having a similar appearance to the muscular tissue of the uterus due to their origin from the smooth muscle cells. Depending on their location within the uterus, fibroids may cause different symptoms and complications, such as pelvic pain, pressure, or urinary problems.
Understanding their appearance can help individuals identify potential fibroid-related issues and seek appropriate medical care.
Understanding the Types of Fibroids and Their Impact
Fibroids can be classified into three main types: subserosal, intramural, and submucosal. Subserosal fibroids grow on the outer surface of the uterus, while intramural fibroids develop within the muscular wall of the uterus. Submucosal fibroids protrude into the uterine cavity.
While all types of fibroids can cause discomfort and complications, submucosal fibroids are often associated with more severe symptoms. These fibroids can lead to heavy menstrual bleeding, pain, and fertility issues. However, it’s important to remember that the severity of symptoms can vary from person to person. Seeking professional evaluation is crucial to understand the individual impact of fibroids and make informed decisions regarding treatment options.
The Intricate Locations of Fibroids: Subserosal, Intramural, and Submucosal
Fibroids can develop in different locations within the uterus. They may be found on the outer surface (subserosal), within the muscular wall (intramural), or protruding into the uterine cavity (submucosal).
The precise location of fibroids plays a significant role in determining the symptoms experienced and the available treatment options. For instance, subserosal fibroids, located on the outer surface of the uterus, may cause pressure or discomfort on nearby organs, while submucosal fibroids, which grow into the uterine cavity, can lead to heavy menstrual bleeding, pain, and fertility issues. Identifying the precise location is essential for effective management and personalized treatment plans.
Unveiling the Growth Patterns of Fibroids: Factors and Variability
Fibroids have the potential to grow over time. Factors such as hormonal changes, genetic predisposition, and estrogen levels can influence their growth patterns. Some fibroids may grow slowly or remain stable, while others may expand rapidly.
Additionally, certain treatments, such as hormone therapy or pregnancy, can impact fibroid growth. It is important to monitor fibroids and consult with a healthcare provider to determine the appropriate management approach, as fibroids do not typically shrink or go away on their own. Certain treatment options, such as medication or surgery, may be recommended to control symptoms, reduce the size of fibroids, or remove them completely.
Fibroids and Their Impact on Menstruation: Heavy Bleeding, Pain, and Irregular Cycles
Uterine fibroids, the most prevalent tumors among women of reproductive age, remain without symptoms in at least 50% of affected individuals.
Nonetheless, when symptoms do manifest, fibroids can have a significant impact on the menstrual cycle and bleeding pattern. Typical symptoms encompass heavy or prolonged menstrual periods, dysmenorrhea (painful periods), and irregular bleeding. The presence of fibroids disrupts the body’s natural hormonal balance, leading to these alterations.
Submucosal fibroids, in particular, can disrupt the uterine lining and result in excessive bleeding. Accurate diagnosis and understanding of how fibroids affect menstruation are vital in determining the most appropriate treatment options, including hormonal medications, minimally invasive procedures, or surgery, for effective symptom management.
Debunking Myths: Cancer, Infertility, and the Persistence of Fibroids
There are several misconceptions surrounding fibroids. Contrary to popular belief, fibroids are typically noncancerous growths. However, in rare cases, certain types of fibroids, such as leiomyosarcoma, may have the potential to develop into cancerous tumors. It is important to note that leiomyosarcoma is a very rare occurrence.
Furthermore, while fibroids can affect fertility, they do not always cause infertility. The impact of fibroids on fertility depends on various factors, including the size, location, and number of fibroids. Treatment options are available to address fibroids and improve fertility outcomes.
Lastly, fibroids do not typically go away on their own or shrink without medical intervention. Although some fibroids may shrink after menopause due to the decrease in estrogen levels, monitoring and management are necessary to ensure optimal health and quality of life for individuals with fibroids.
Treatment of Fibroids: Managing Symptoms and Improving Quality of Life
When fibroids cause significant symptoms or complications, various treatment options are available to help manage the condition. Hormonal medications, such as birth control pills or gonadotropin-releasing hormone agonists, may be prescribed to regulate hormonal levels and control symptoms like heavy bleeding or pain. Minimally invasive procedures, such as uterine artery embolization or focused ultrasound surgery, can be used to target and shrink fibroids. In more severe cases, surgery, such as myomectomy (removal of fibroids while preserving the uterus) or hysterectomy (surgical removal of the uterus), may be recommended to remove fibroids or the entire uterus.
The current landscape of fibroid treatment options is limited, with a lack of diverse choices to address the condition. Additionally, some of the available treatments carry inherent risks and limitations, underscoring the need for more effective and safer alternatives to improve patient outcomes and quality of life.
A recent research published in the Lancet journal on September 17, 2022, has shed light on a potential breakthrough. The study highlights the drug Linzagolix, which interferes with estrogen production and has shown promising results in not just managing symptoms but also shrinking fibroids. This development offers hope for expanding the range of minimally invasive fibroid treatment options.
Dr. Hugh S. Taylor, a professor at Yale and one of the study authors, expresses his enthusiasm for these discoveries. He explains that previous treatments for fibroid growth have not addressed the underlying cause of the problem and are not suitable for long-term use. Dr. Hugh S. Taylor says that:
“No treatments to date for fibroid growth are something I would ever want my patients to take for a prolonged period of time, as they did not treat the underlying cause of the problem.”
Linzagolix belongs to a class of drugs that are remarkably well-tolerated and have the potential to control fibroid growth effectively. This represents a significant advancement in fibroid treatment options that has not been available before.
All things considered, the choice of treatment depends on factors such as the severity of symptoms, desire for future fertility, and overall health. Consulting with healthcare professionals is crucial in determining the most suitable treatment approach for each individual.
Now back to the original question: what are fibroids? Fibroids are common noncancerous growths that can affect the uterus. Understanding their appearance, location, types, growth patterns, and impact on menstruation is crucial for individuals seeking proper diagnosis and treatment. Dispelling common myths associated with fibroids, such as their potential for cancer, infertility, and spontaneous shrinkage, can help individuals make informed decisions about their healthcare. Consulting with healthcare professionals is essential to develop personalized treatment plans and effectively manage fibroids for improved overall well-being.
7 Gynecological Fibroid Myths Debunked | Fibroid Institute Dallas. (2021, November 12). Fibroid Institute Texas. Retrieved on July 16 from https://www.fibroidfree.com/fibroids/debunking-gynecological-fibroid-myths/
Backman, I. (n.d.). Promising Trial for a Drug to Ease Uterine Fibroids. Medicine.yale.edu. Retrieved July 18, 2023, from https://medicine.yale.edu/news-article/promising-trial-for-a-drug-to-ease-uterine-fibroids/
Cruz, M. S. D. D. L., & Buchanan, E. M. (2017). Uterine Fibroids: Diagnosis and Treatment. American Family Physician, 95(2), 100–107. Retrieved on July 16 from https://www.aafp.org/pubs/afp/issues/2017/0115/p100.html?utm_medium=email&utm_source=transaction
Debunking These 10 Uterine Fibroid Myths. (2019, January 25). Azura Vascular Care. Retrieved on July 16 from https://www.azuravascularcare.com/infoufe/debunking-10-uterine-fibroid-myths/
Donnez, J., & Dolmans, M.-M. (2016). Uterine fibroid management: from the present to the future. Human Reproduction Update, 22(6), 665–686. Retrieved on July 16 from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853598/
Freytag, D., Günther, V., Maass, N., & Alkatout, I. (2021). Uterine Fibroids and Infertility. Diagnostics, 11(8), 1455. Retrieved on July 16 from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391505/
Gupta, S., Jose, J., & Manyonda, I. (2008). Clinical presentation of fibroids. Best Practice & Research. Clinical Obstetrics & Gynaecology, 22(4), 615–626. Retrieved on July 16 from https://www.sciencedirect.com/science/article/abs/pii/S1521693408000217
Machado-Lopez, A., Simón, C., & Mas, A. (2021). Molecular and Cellular Insights into the Development of Uterine Fibroids. International Journal of Molecular Sciences, 22(16), 8483. Retrieved on July 16 from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395213/
Navarro, A., Bariani, M. V., Yang, Q., & Al-Hendy, A. (2021). Understanding the Impact of Uterine Fibroids on Human Endometrium Function. Frontiers in Cell and Developmental Biology, 9. Retrieved on July 16 from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186666/
Sankaran, S., & Manyonda, I. T. (2008). Medical management of fibroids. Best Practice & Research Clinical Obstetrics & Gynaecology, 22(4), 655–676. Retrieved on July 16 from https://www.sciencedirect.com/science/article/abs/pii/S1521693408000461
Sefah, N., Ndebele, S., Prince, L., Korasare, E., Agbleke, M., Nkansah, A., Thompson, H., Al-Hendy, A., & Agbleke, A. A. (2023). Uterine fibroids — Causes, impact, treatment, and lens to the African perspective. Frontiers in Pharmacology, 13. Retrieved on July 16 from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871264/
Uimari, O., Subramaniam, K. S., Vollenhoven, B., & Tapmeier, T. T. (2022). Uterine Fibroids (Leiomyomata) and Heavy Menstrual Bleeding. Frontiers in Reproductive Health, 4. Retrieved on July 16 from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580818/
Wilde, S., & Scott-Barrett, S. (2009). Radiological appearances of uterine fibroids. The Indian Journal of Radiology & Imaging, 19(3), 222–231. Retrieved on July 16 fromhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766886/